Fidson vs. May & Baker: Which pharma stock offers better value for investors?
So far in 2025, Fidson has delivered a 177% YtD gain, the best in the sector. May & Baker, with ...
News and analysis about Fidson Healthcare Plc
So far in 2025, Fidson has delivered a 177% YtD gain, the best in the sector. May & Baker, with ...
Fidson Healthcare Plc has signed a memorandum of understanding to expand its partnership with Japanese firm, Ohara Pharmaceutical Co. Ltd.
In a significant move set to transform Africa’s healthcare landscape, a delegation from Nigeria’s leading pharmaceutical manufacturer, Fidson Healthcare Plc, ...
In this interview with Nairametrics, Dr Ayebae says he has been inspired by his friend, Aliko Dangote, as he reveals ...
Fidson Healthcare Plc has unveiled an ambitious plan to invest $50 million over the next three years, leveraging equity and ...
Fidson Healthcare Plc has released its financial results for the first quarter ended 31st March 2025, reporting a pre-tax profit ...
Shares of Fidson Healthcare Plc rose by 24% in the first week of February 2025, with a trading volume of ...
Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc announces the appointment of three new Directors. This strategic move, made by the ...
Fidson Healthcare Plc’s stock dropped to a 52-week low of N12.5 per share at the start of trading on August ...
During the company’s Annual General Meeting on July 4, 2024, its shareholders approved the resolution which authorizes its directors to ...